Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hyssop (Hyssopus officinalis) contains volatile oils including pinocamphone and isopinocamphone that provide expectorant and antimicrobial effects. Clinical evidence supports its use for respiratory conditions, particularly productive cough and asthma management.
Origin & History
Zufa (Hyssopus officinalis), commonly known as hyssop, is a perennial aromatic herb from the Lamiaceae family native to the Mediterranean region, southern Europe, and Central Asia. The aerial parts (leaves, stems, and flowers) are extracted using methanol, ethanol, or water-based methods to yield polyphenolic-rich fractions containing flavonoids and essential oils.
Research Narrative (Provisional)
Limited human clinical evidence exists, with one randomized triple-blind placebo-controlled trial (n=60 mild-to-moderate asthmatic patients) testing hyssop syrup as adjuvant therapy for 4 weeks (PMID: 39959798). Most evidence comes from preclinical studies including in vitro PBMC studies demonstrating immune activation (PMID: 36503515) and animal asthma models (PMC4186396).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Hyssopus officinalis (Zufa) is a aromatic herb with limited macronutrient caloric value in typical culinary/medicinal doses. Key nutritional and bioactive components include: Essential Oils (0.3–2.0% dry weight): Dominated by pinocamphone (25–50%), isopinocamphone (15–35%), β-pinene (10–15%), and camphor (5–15%). These monoterpenes and ketones are the primary bioactive drivers. Bioavailability is enhanced via inhalation and oral mucosa absorption; hepatic first-pass metabolism reduces systemic availability of oral forms. Flavonoids (1–3% dry weight): Diosmin (~0.5–1.0%), hesperidin, luteolin, apigenin, and rutin. These exhibit moderate oral bioavailability (~20–40%), improved with food lipids. Diosmin demonstrates vascular and anti-inflammatory activity at these concentrations. Phenolic Acids: Rosmarinic acid (~0.5–1.5 mg/g dry weight), chlorogenic acid, and caffeic acid. Rosmarinic acid has moderate bioavailability (~30%) with antioxidant and anti-inflammatory properties relevant to respiratory mucosa. Terpenes: Ursolic acid and oleanolic acid (triterpenoids, ~0.1–0.5%), with low oral bioavailability (<10%) but meaningful mucosal activity. Tannins: ~3–8% dry weight; may bind minerals (iron, zinc) reducing their absorption if consumed in large quantities. Minerals (per 100g dried herb): Calcium (~1200 mg), potassium (~700 mg), magnesium (~150 mg), iron (~30 mg, but tannin-bound, low bioavailability ~5–10%), manganese (~3 mg). Vitamins: Vitamin C (~50–80 mg/100g dried), vitamin A precursors (beta-carotene ~2–4 mg/100g), vitamin K (~200–400 µg/100g — relevant for anticoagulant drug interactions). Macronutrients (per 100g dried): Protein ~5–7g, carbohydrates ~30–40g (primarily fiber), fat ~3–5g (largely polyunsaturated from seed oil components). Caloric density ~250–300 kcal/100g but irrelevant at medicinal doses (1–5g/day). Bioavailability Notes: Pinocamphone crosses the blood-brain barrier readily; flavonoid absorption is enhanced by gut microbiota metabolism to smaller phenolic metabolites; high tannin content may chelate minerals and reduce absorption of co-administered medications; fat-soluble components (terpenoids) benefit from co-administration with dietary fat.
Reported Mechanism (Provisional)
Hyssop's volatile oils, particularly pinocamphone and isopinocamphone, act as expectorants by stimulating mucus secretion and ciliary clearance in respiratory tissues. The herb's flavonoids and phenolic compounds demonstrate antimicrobial activity against respiratory pathogens and modulate inflammatory pathways including NF-κB signaling.
Clinical Narrative (Provisional)
One randomized clinical trial (n=60) demonstrated that hyssop syrup as adjuvant therapy significantly improved Asthma Control Test scores and pulmonary function in patients with productive cough, particularly those with higher BMI. In vitro studies show antiviral activity against respiratory pathogens. However, human clinical evidence remains limited to single studies, requiring additional research to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.